NCT00077987View on ClinicalTrials.gov

Assessment Of Safety And Efficacy Of SU11248 In Patients With Metastatic Colorectal Cancer Who Have Failed Selected Previous Treatments.

PHASE2CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

December 31, 2003

Study Completion Date

April 30, 2005

Conditions
Colorectal Neoplasms
Interventions
DRUG

SU011248

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00077987 - Assessment Of Safety And Efficacy Of SU11248 In Patients With Metastatic Colorectal Cancer Who Have Failed Selected Previous Treatments. | Biotech Hunter | Biotech Hunter